These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18549982)

  • 21. Productivity shortfalls in drug discovery: contributions from the preclinical sciences?
    Williams M
    J Pharmacol Exp Ther; 2011 Jan; 336(1):3-8. PubMed ID: 20739456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficiency versus quality in the NHS, in Portugal: methodologies for evaluation].
    Giraldes Mdo R
    Acta Med Port; 2008; 21(5):397-410. PubMed ID: 19187682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of non-profit organizations on drug discovery: opportunities, gaps, solutions.
    Matter A; Keller TH
    Drug Discov Today; 2008 Apr; 13(7-8):347-52. PubMed ID: 18405848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selection of licensing candidates in the pharmaceutical industry: an application of the analytic hierarchy process.
    Ross ME; Nydick RL
    J Health Care Mark; 1992 Jun; 12(2):60-5. PubMed ID: 10119215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scientific workflows as productivity tools for drug discovery.
    Shon J; Ohkawa H; Hammer J
    Curr Opin Drug Discov Devel; 2008 May; 11(3):381-8. PubMed ID: 18428092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rebuilding the R&D engine in big pharma.
    Garnier JP
    Harv Bus Rev; 2008 May; 86(5):68-70, 72-6, 128. PubMed ID: 18543809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using an action research process in pharmacy practice research--a cooperative project between university and internship pharmacies.
    Sørensen EW; Haugbølle LS
    Res Social Adm Pharm; 2008 Dec; 4(4):384-401. PubMed ID: 19064245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficient and effective compound management to support lead optimization.
    Johnson CW; Chatterjee M; Kubala S; Helm D; Houston J; Banks M
    J Biomol Screen; 2009 Jun; 14(5):523-30. PubMed ID: 19483145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gentris corporation.
    Crean J
    Pharmacogenomics; 2002 Jan; 3(1):148-50. PubMed ID: 11966411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brazil: An emerging partner in drug R&D.
    Rodrigues DG
    IDrugs; 2009 Aug; 12(8):497-502. PubMed ID: 19629884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An unbalanced portfolio.
    Federsel HJ
    Drug News Perspect; 2009 Jun; 22(5):287-92. PubMed ID: 19609466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissecting delays in trauma care using corporate lean six sigma methodology.
    Parks JK; Klein J; Frankel HL; Friese RS; Shafi S
    J Trauma; 2008 Nov; 65(5):1098-104; discussion 1104-5. PubMed ID: 19001981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Indian and Chinese health biotechnology industries: potential champions of global health?
    Frew SE; Kettler HE; Singer PA
    Health Aff (Millwood); 2008; 27(4):1029-41. PubMed ID: 18607038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug discovery: new models for industry-academic partnerships.
    Tralau-Stewart CJ; Wyatt CA; Kleyn DE; Ayad A
    Drug Discov Today; 2009 Jan; 14(1-2):95-101. PubMed ID: 18992364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Strategy of molecular drug design: hits, leads and drug candidates].
    Guo ZR
    Yao Xue Xue Bao; 2008 Sep; 43(9):898-904. PubMed ID: 19048779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outsourcing lead optimisation--the quiet revolution.
    Clark DE; Newton CG
    Drug Discov Today; 2004 Jun; 9(11):492-500. PubMed ID: 15149625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The promise of a virtual lab in drug discovery.
    Rauwerda H; Roos M; Hertzberger BO; Breit TM
    Drug Discov Today; 2006 Mar; 11(5-6):228-36. PubMed ID: 16580600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The paradox of scientific excellence and the search for productivity in pharmaceutical research and development.
    Grasela TH; Slusser R
    Clin Pharmacol Ther; 2014 May; 95(5):521-7. PubMed ID: 24458012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The good work--a Swedish trade union vision in the shadow of lean production.
    Johansson J; Abrahamsson L
    Appl Ergon; 2009 Jul; 40(4):775-80. PubMed ID: 18838130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Team-level predictors of innovation at work: a comprehensive meta-analysis spanning three decades of research.
    Hülsheger UR; Anderson N; Salgado JF
    J Appl Psychol; 2009 Sep; 94(5):1128-45. PubMed ID: 19702361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.